May 14 Product: Dynavaxs Heplisav-B Indication: Hepatitis B patients undergoing hemodialysis The FDA declined to approve the supplemental Biologics License Application for Dynavax Technologies hepatitis B vaccine in patients undergoing hemodialysis, deeming the safety and efficacy data submitted by the company insufficient
Dull Skin: Both ingredients work together to improve radiance and smooth texture
Right-upper-abdominal pain, fever, or jaundice can suggest gallbladder disease
N- hexanoyl-Tyr-Ile-(6) aminohexamide was further evaluated and found to have spectacularly augment HGF-dependent MDCK cell scattering
Case report An 82-year-old man with a history of coronary artery disease and noninvasive low-grade papillary urothelial carcinoma was evaluated for a slightly raised, well-demarcated, homogenously dark-brown plaque with irregular borders at the penile urethral meatus
Evans PL, McMillin SL, Weyrauch LA, Witczak CA